UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2016-09, Vol.27 (suppl 5), p.v28-v37

2016

Volltextzugriff (PDF)

Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced/metastatic biliary tumors: REACHIN, a randomized, double-blind, phase II trial

Annals of oncology, 2020-09, Vol.31 (9), p.1169-1177

2020

Volltextzugriff (PDF)

Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms

Endocrine-related cancer, 2015-08, Vol.22 (4), p.657-664

2015

Volltextzugriff (PDF)

Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study

Annals of oncology, 2017-02, Vol.28 (2), p.339-343

2017

Volltextzugriff (PDF)

VP10-2021: Cabozantinib (C) plus atezolizumab (A) versus sorafenib (S) as first-line systemic treatment for advanced hepatocellular carcinoma (aHCC): Results from the randomized phase III COSMIC-312 trial

Annals of oncology, 2022-01, Vol.33 (1), p.114-116

2022

Volltextzugriff (PDF)

Design and Investigation of Molybdenum Modified Platinum Surfaces for Modeling of CO Tolerant Electrocatalysts

Topics in catalysis, 2018-09, Vol.61 (14), p.1385-1395

2018

Volltextzugriff (PDF)

A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial

Annals of oncology, 2017-06, Vol.28 (6), p.1309-1315

2017

Volltextzugriff (PDF)

The "Fonds Georges Brohée": a longstanding Belgian national initiative to stimulate research in hepatogastroenterology

Acta gastro-enterologica belgica, 2021-01, Vol.84 (1), p.91-94

2021

Volltextzugriff (PDF)

High performance magnetorheological fluids: very high magnetization FeCo–Fe3O4 nanoclusters in a ferrofluid carrier

Soft matter, 2022-01, Vol.18 (3), p.626-639

2022

Volltextzugriff (PDF)

Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study

BMC cancer, 2021-05, Vol.21 (1), p.578-578, Article 578

2021

Volltextzugriff (PDF)

In Memoriam: René Fiasse (1936-2024)

Acta gastro-enterologica belgica, 2024-04, Vol.87 (2), p.346-347

2024

Volltextzugriff (PDF)

Novel Pt Electrocatalysts: Multifunctional Composite Supports for Enhanced Corrosion Resistance and Improved CO Tolerance

Topics in catalysis, 2018-08, Vol.61 (12-13), p.1300-1312

2018

Volltextzugriff (PDF)

Exclusive formation of alloy phases via anchoring technique—From bimetallic catalysts to electrocatalysis

Catalysis today, 2018-05, Vol.306, p.58-70

2018

Volltextzugriff (PDF)

Watch-an-wait strategy for multiple rectal neuroendocrine tumors with widespread invasion

Acta gastro-enterologica belgica, 2023-10, Vol.86 (4), p.563-565

2023

Volltextzugriff (PDF)

Belgian guidelines for pathology reporting of neuroendocrine neoplasms of the pancreaticobiliary and gastrointestinal tract. Initialized by the Belgian Group of Digestive Oncology (BGDO) and supported by the BGDO, the BSP (Belgian Society of Pathology) and the BCR (Belgian Cancer Registry)

Acta gastro-enterologica belgica, 2023-06, Vol.86 (2), p.345-351

2023

Volltextzugriff (PDF)

Pancreatic neuroendocrine tumour grading on endoscopic ultrasound-guided fine needle aspiration: high reproducibility and inter-observer agreement of the Ki-67 labelling index

Cytopathology (Oxford), 2014-12, Vol.25 (6), p.389-395

2014

Volltextzugriff (PDF)

Metastatic cancer in an uncommon location: importance of clinico-pathological correlation

Acta gastro-enterologica belgica, 2022-04, Vol.85 (2), p.408-409

2022

Volltextzugriff (PDF)

Pancreatic cancer organoids as a tool for developing personalized therapies

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2020-11, Vol.20, p.S134-S134

2020

Volltextzugriff (PDF)

Misleading clinical presentation of carcinoid syndrome

Acta gastro-enterologica belgica, 2021-07, Vol.84 (3), p.501-503

2021

Volltextzugriff (PDF)

Expert opinion on management of pancreatic exocrine insufficiency in pancreatic cancer

ESMO open, 2022-02, Vol.7 (1), p.100386-100386, Article 100386

2022

Volltextzugriff (PDF)

Human equilibrative nucleoside transporter 1 (hENT1) expression is a potential predictive tool for response to gemcitabine in patients with advanced cholangiocarcinoma

European journal of cancer (1990), 2012-05, Vol.48 (7), p.990-996

2012

Volltextzugriff (PDF)

Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digestive Oncology

Annals of oncology, 2013-11, Vol.24 (11), p.2824-2829

2013

Volltextzugriff (PDF)

A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial

Annals of oncology, 2019-11, Vol.30 (11), p.1846-1846

2019

Volltextzugriff (PDF)

Lessons learned about appendiceal neuroendocrine neoplasms from data analysis of the Belgian Cancer Registry 2010-2015

Acta gastro-enterologica belgica, 2021-07, Vol.84 (3), p.458-466

2021

Volltextzugriff (PDF)

Exploratory analysis based on tumor location of REACHIN, a randomized, double-blinded, placebo-controlled phase 2 trial of regorafenib after failure of gemcitabine and platinum-based chemotherapy for advanced/metastatic biliary tract tumors

Annals of oncology, 2019-07, Vol.30, p.iv127-iv127

2019

Volltextzugriff (PDF)

1 – 25 von 442

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(398)
Mit Volltextzugriff
(394)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced/metastatic biliary tumors: REACHIN, a randomized, double-blind, phase II trial

Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms

Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study

VP10-2021: Cabozantinib (C) plus atezolizumab (A) versus sorafenib (S) as first-line systemic treatment for advanced hepatocellular carcinoma (aHCC): Results from the randomized phase III COSMIC-312 trial

Design and Investigation of Molybdenum Modified Platinum Surfaces for Modeling of CO Tolerant Electrocatalysts

A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial

The "Fonds Georges Brohée": a longstanding Belgian national initiative to stimulate research in hepatogastroenterology

High performance magnetorheological fluids: very high magnetization FeCo–Fe3O4 nanoclusters in a ferrofluid carrier

Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study

In Memoriam: René Fiasse (1936-2024)

Novel Pt Electrocatalysts: Multifunctional Composite Supports for Enhanced Corrosion Resistance and Improved CO Tolerance

Exclusive formation of alloy phases via anchoring technique—From bimetallic catalysts to electrocatalysis

Watch-an-wait strategy for multiple rectal neuroendocrine tumors with widespread invasion

Belgian guidelines for pathology reporting of neuroendocrine neoplasms of the pancreaticobiliary and gastrointestinal tract. Initialized by the Belgian Group of Digestive Oncology (BGDO) and supported by the BGDO, the BSP (Belgian Society of Pathology) and the BCR (Belgian Cancer Registry)

Pancreatic neuroendocrine tumour grading on endoscopic ultrasound-guided fine needle aspiration: high reproducibility and inter-observer agreement of the Ki-67 labelling index

Metastatic cancer in an uncommon location: importance of clinico-pathological correlation

Pancreatic cancer organoids as a tool for developing personalized therapies

Misleading clinical presentation of carcinoid syndrome

Expert opinion on management of pancreatic exocrine insufficiency in pancreatic cancer

Human equilibrative nucleoside transporter 1 (hENT1) expression is a potential predictive tool for response to gemcitabine in patients with advanced cholangiocarcinoma

Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digestive Oncology

A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial

Lessons learned about appendiceal neuroendocrine neoplasms from data analysis of the Belgian Cancer Registry 2010-2015

Exploratory analysis based on tumor location of REACHIN, a randomized, double-blinded, placebo-controlled phase 2 trial of regorafenib after failure of gemcitabine and platinum-based chemotherapy for advanced/metastatic biliary tract tumors

Suchergebnisse filtern